Global Amyotrophic Lateral Sclerosis Treatment Market Share

Market Share of Global Amyotrophic Lateral Sclerosis Treatment Industry

The amyotrophic lateral sclerosis treatment market is slightly fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some companies are Mitsubishi Tanabe Pharma Corporation, Sun Pharmaceutical Industries Ltd., CORESTEM, Inc, BrainStorm Cell Limited, Amylyx Pharmaceuticals Inc., AB Science, Ionis Pharmaceuticals, Biohaven Pharmaceutical, Biogen, and F.Hoffmann-La Roche AG.

Amyotrophic Lateral Sclerosis (ALS) Treatment Market Leaders

1. Mitsubishi Tanabe Pharma Corporation

2. CORESTEM, Inc

3. BrainStorm Cell Limited

4. Amylyx Pharmaceuticals Inc.

5. Biogen

*Disclaimer: Major Players sorted in no particular order